Risultati per 'Covance':
Di seguito l'elenco dei risultati di ricerca trovati rilevanti per la keyword 'Covance':
Risultati maggiormente rilevanti:
covance is now labcorp drug development
Labcorp Drug Development (formerly Covance) is a global contract research organization (CRO) that provides drug development services with the goal of advancing health. We have supported the development of the top 50 pharmaceutical drugs on the market. As a full-service CRO, we are dedicated to providing nonclinical, preclinical, clinical, commercialization and regulatory consulting, research ...
investigator portal© 2022 Labcorp. All rights reserved. Version 2022.0.2; Terms and Conditions; Privacy policy; Contact Us
covance inc. -- company historyCovance, the former Corning Pharmaceutical Services, established headquarters in Princeton, New Jersey. The company had net revenues of $494.8 million in 1996 and net income of $12.7 million. It increased these figures to $590.7 million and $39.8 million, respectively, in 1997, and $731.6 million and $48.6 million, respectively, in 1998.
Altri risultati:
labcorp drug development - wikipediaLabcorp Drug Development is a contract research organization (CRO) headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries.Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide.. Labcorp Drug Development claims to provide the world's ...
vmware horizonCheck here to skip this screen and always use Native Client.
investigator portalThis site is for the exclusive use of Labcorp Drug Development clients. Any other attempt at usage is strictly prohibited. Labcorp has security procedures in place for the purpose of protecting the security of data available through Xcellerate Investigator Portal, both technical and operational measures, including the use of passwords, restricted access to databases, the use of 128-bit ...
labcorp drug developmentLabcorp Drug Development